Related Experiment Video
Updated: Jul 18, 2026
07:38
Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
[Left ventricular hypertrophy in chronic kidney disease].
1Divisione di Nephrologia, Dialisi e Trapianto, Azienda Ospedaliera Universitaria S. Martino, Genova. ernesto.paoletti@hsanmartino.it
Summary
Chronic kidney disease (CKD) patients often develop left ventricular hypertrophy (LVH), increasing cardiovascular risk. Early diagnosis and treatment of LVH in CKD can reverse poor outcomes and improve survival.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Context:
- Chronic kidney disease (CKD) significantly elevates cardiovascular (CV) risk.
- Left ventricular hypertrophy (LVH) is highly prevalent in CKD patients, even early on.
- LVH in CKD results from combined hemodynamic and non-hemodynamic factors, notably anemia and hypertension.
Purpose:
- To explore the multifactorial pathogenesis of LVH in CKD.
- To review therapeutic strategies for LVH regression in CKD patients.
- To emphasize early diagnosis and management of LVH for improved patient outcomes.
Summary:
- CKD is linked to increased CV risk, with LVH being a major concern.
- Anemia and hypertension are key drivers of LVH in CKD.
- Therapies targeting anemia (epoetin) and hypertension (ACE inhibitors) can regress LVH.
- Early echocardiographic diagnosis, risk factor screening, and monitoring are crucial.
- Reversing LVH can improve survival and reduce CV events in CKD patients.
Impact:
- Highlights the critical link between CKD, LVH, and cardiovascular outcomes.
- Underscores the importance of managing anemia and hypertension in CKD.
- Demonstrates that LVH regression is achievable and beneficial.
- Advocates for early and proactive management strategies in CKD care.
- Aims to improve the overall prognosis and quality of life for CKD patients.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...